Wayne Burris - May 31, 2024 Form 4 Insider Report for Accelerate Diagnostics, Inc (AXDX)

Role
Director
Signature
/s/ David Patience, attorney-in-fact
Stock symbol
AXDX
Transactions as of
May 31, 2024
Transactions value $
$0
Form type
4
Date filed
6/3/2024, 05:06 PM
Previous filing
May 21, 2024
Next filing
Jun 20, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction AXDX Common Stock Options Exercise $0 +839 +100% $0.00 1.68K May 31, 2024 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction AXDX Restricted Stock Units Options Exercise $0 -839 -25% $0.00 2.52K May 31, 2024 Common Stock 839 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each restricted stock unit ("RSU") represents a contingent right to receive one share of the issuer's common stock upon vesting.
F2 On May 31, 2022, the reporting person was granted a total of 4,195 RSUs, which vest in five equal annual installments beginning on May 31, 2023.

Remarks:

On July 11, 2023, the issuer effected a reverse stock split of its common stock at a ratio of 1-for-10 (the "Reverse Stock Split"). As a result of the Reverse Stock Split, proportionate adjustments were made to the number of shares of the issuer's common stock underlying its outstanding equity awards, warrants and convertible notes, as well as the exercise or conversion price, as applicable. The amounts reported after the effective date of the Reverse Stock Split, including the amounts reported herein (and to be reported in subsequent reports), have been adjusted to reflect the Reverse Stock Split.